Latest filing published 10 Sept 2026 for Lyell Immunopharma, Inc., €5,457. Read the official filing
David Shook discloses dealings in 2 companies, chiefly Nkarta, Inc. and Lyell Immunopharma, Inc. In total, 12 filings cover trades dated from 13 January 2023 to 10 September 2026.
Every open-market trade on record is a sale: 6 sales worth €59k. The rest of the record consists of 6 share grants. So far in 2026, the count stands at no purchases and 1 sale.
On 10 September 2026 came the latest disclosure, an open-market sale for €5,457 in Lyell Immunopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations